Ikarian Capital, LLC Compugen LTD Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Compugen LTD stock. As of the latest transaction made, Ikarian Capital, LLC holds 500 shares of CGEN stock, worth $720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$720% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.3MCall Options Held
28.7KPut Options Held
48.3K-
Silverarc Capital Management, LLC2.9MShares$4.17 Million1.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.4MShares$2.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.39MShares$2 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.05MShares$1.51 Million0.94% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.47 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $125M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...